1[1]McLead AD, Friend DR, Tozer TN. Glucocorticiod dextran conjugtes as potential prodrug delivery: Hydrolysis in rat gastrointestinal tract contents [J]. J Pharm Sci, 1994;83(9):1284-1288.
2[2]McLead AD, Friend DR, Tozer TN. Synthesis and chemical stability of glucoc orticoid-dextran esters: Potential prodrugs for colon-specific delivery [J]. Int J Pharm,1993;92(2): 105-114.
3[3]Hanninen O, Lindstrom-Sppa P, Pelkonen K. Role of gut in xenobiotic metabolism [J]. Arch Toxico,1987;60(1): 34-36.
4[4]Williams-Smiths H. Observations on the flora of the alimentary tract of anim als and factors affecting its composition [J]. J Phathol Bacteriol,1965;89 (2): 95-122.
5[5]Davis SS, Hardy JG, Fara JW. Transit of pharmaceutical dosage forms through the small intestine [J]. Gut,1986;27(8): 886-892.
6[6]Hardy JG,Wilson CG, Wood E. Drug delivery to the proximal colon [J ]. J Pharm Pharmacol,1985;37(12): 847-877.
4Rodríguez M,Vila-Jatto JL,Torres D.Design of a new multiparticulate system for potential site-specific and controlled drug delivery to the colonic region[J].J Control Release,1998,55(1):671.
5Doh MU,Jung YJ,Kim I,et al.Synthesis and in vitro properties of prednisolone 21-sulfate sodium as colon-specific prodrug of prednisolone[J].Arch Pharm Res,2003,26(4):2558.
7Ezpeleta I,Arangoa MA.Preparation of Ulex europaeus lectin-gliadin nanoparticle conjugates and their interaction with gastrointestinal mucus[J].Int J Pharm,1999,191(1):25.
8Umamaheshwari RB,Jain NK.Receptor mediated targeting of lectin conjugated gliadin nanoparticles in the treatment of Helicobacter pylori[J].J Drug Target,2003,11(7):415.
9Motoki M,Hu Zp,Tatsuharu S,et al.Evaluation of intestinal pressure-controlled colon delivery capsule containing caffeine as a model drug in human volunteers[J].J Control Release,1998,52(12):118.
10Rasmane S,Karim A,Schouwer D,et al.Studies of pectin HM/ Eudragit(R) RL/ Eudragit(R) NE film-coatingformulations intended for colonic drug delivery[J].Int J Pharm,2000,197(3):181.
